ES2054089T3 - Formulaciones orales liquidas. - Google Patents

Formulaciones orales liquidas.

Info

Publication number
ES2054089T3
ES2054089T3 ES89810825T ES89810825T ES2054089T3 ES 2054089 T3 ES2054089 T3 ES 2054089T3 ES 89810825 T ES89810825 T ES 89810825T ES 89810825 T ES89810825 T ES 89810825T ES 2054089 T3 ES2054089 T3 ES 2054089T3
Authority
ES
Spain
Prior art keywords
oral formulations
liquid oral
formulation
diclofenac
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89810825T
Other languages
English (en)
Inventor
Heidi Dr Affolter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2054089T3 publication Critical patent/ES2054089T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

EL OBJETO DEL INVENTO ES UN PREPARADO FARMACEUTICO ACUOSO UTILIZADO POR VIA ORAL, FORMADO POR DICLOFENAC Y EMPLEADO EN EL TRATAMIENTO DE ESTADOS DE DOLOR Y DE PROCESOS DE INFLAMACION Y DESCRIBE LA PRODUCCION DEL PREPARADO FARMACEUTICO.
ES89810825T 1988-11-10 1989-11-01 Formulaciones orales liquidas. Expired - Lifetime ES2054089T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH416788 1988-11-10

Publications (1)

Publication Number Publication Date
ES2054089T3 true ES2054089T3 (es) 1994-08-01

Family

ID=4271057

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89810825T Expired - Lifetime ES2054089T3 (es) 1988-11-10 1989-11-01 Formulaciones orales liquidas.

Country Status (16)

Country Link
EP (1) EP0373103B1 (es)
JP (1) JP2894744B2 (es)
KR (1) KR0152983B1 (es)
AT (1) ATE87476T1 (es)
AU (1) AU624190B2 (es)
CA (1) CA2002472C (es)
DE (1) DE58903964D1 (es)
DK (1) DK175752B1 (es)
ES (1) ES2054089T3 (es)
GR (1) GR3007995T3 (es)
IE (1) IE63482B1 (es)
IL (1) IL92190A (es)
NZ (1) NZ231320A (es)
PT (1) PT92228B (es)
SA (1) SA90100152B1 (es)
ZA (1) ZA898554B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011688A (en) * 1989-02-02 1991-04-30 Calam Henry D Liquid composition for the relief of premenstrual and menstrual discomforts
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
WO2002011716A2 (en) 2000-08-07 2002-02-14 Ranbaxy Signature Llc Liquid formulation of metformin
ITMI20020986A1 (it) * 2002-05-10 2003-11-10 Acraf Composizione a base di diclofenac per il trattamento topico di affezioni del cavo orofaringeo
JP2004059488A (ja) * 2002-07-29 2004-02-26 Asahi Food & Healthcare Ltd 乳酸菌整腸組成物および食品
JP2006315966A (ja) * 2005-04-11 2006-11-24 Sanei Gen Ffi Inc 黒豆抽出物を含有した咽喉頭用液状組成物
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
IN2014CN02850A (es) 2011-10-31 2015-07-03 Glaxosmithkline Intellectual Property Ltd

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
JPS5238030A (en) * 1975-07-04 1977-03-24 Gaba Ag Mouth and tooth reparing agent
CH655507B (es) * 1983-01-12 1986-04-30

Also Published As

Publication number Publication date
EP0373103A1 (de) 1990-06-13
IE893611L (en) 1990-05-10
PT92228B (pt) 1995-07-06
NZ231320A (en) 1992-11-25
JPH02178224A (ja) 1990-07-11
PT92228A (pt) 1990-05-31
IE63482B1 (en) 1995-05-03
DK561589D0 (da) 1989-11-09
CA2002472C (en) 2000-05-30
AU4434389A (en) 1990-06-07
CA2002472A1 (en) 1990-05-10
AU624190B2 (en) 1992-06-04
IL92190A (en) 1996-07-23
IL92190A0 (en) 1990-07-26
ZA898554B (en) 1990-08-29
DK561589A (da) 1990-05-11
KR910009253A (ko) 1991-06-28
ATE87476T1 (de) 1993-04-15
KR0152983B1 (ko) 1998-11-16
EP0373103B1 (de) 1993-03-31
DK175752B1 (da) 2005-02-07
GR3007995T3 (es) 1993-08-31
DE58903964D1 (de) 1993-05-06
SA90100152B1 (ar) 2001-04-14
JP2894744B2 (ja) 1999-05-24

Similar Documents

Publication Publication Date Title
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
PT85055A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ester metilico da levodopa
NO882732L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK602783A (da) Farmaceutisk praeparat indeholdende calcitonin
NO157020C (no) AnalogifremgangsmŸte ved fremstilling av terapeutisk aktive 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-aromatiske heterocykliske carboxylater.
ES2054089T3 (es) Formulaciones orales liquidas.
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
FR2618331B1 (fr) Compositions pharmaceutiques utiles pour le traitement de l'uremie
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
OA07270A (fr) Dérivés N-(vinblastinoyl-23) d'acide aminés, leur préparation et leur application thérapeutique.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
IT1162680B (it) N-(1-metil 2-pirrolidinilmetil) 2,3 dimetossi-5-metilsolfamoil benzammi de e suoi derivati utili per il trattamento dei disturbi dell'apparato urinario e procedimento di preparazione
NO167381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv (e)-2-(p-fluorfenethyl)-3-fluorallylamin.
IT8848344A0 (it) Dispositivo per il trattamento delle malattie delle gengive
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
NO883987L (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
IT8719221A0 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro prodecimento di preparazione e relative applicazioni terapeutiche.
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
IT1224897B (it) Composizione farmaceutica per il trattamento delle affezioni parodontali
IT7945204A0 (it) Composizione farmaceutica per la terapia delle sterilita' maschile
IT8620737A0 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro procedimento di preparazione e relative applicazioni terapeutiche.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 373103

Country of ref document: ES